Michele Stansfield

Female-founded fermentation startup Cauldron lands $10.5 million to transform how new foods and fibres are developed

- March 27, 2023 2 MIN READ

Cauldron speeds up development of new food, feedstock and fibre ingredients Its hyper-fermentation platform lowers commercial risk & production costs $10.5m Seed round led by Main Sequence + Horizons Ventures An ambitious plan to transform the way new food, feedstock and fibre ingredients are created, by using fermentation has raised $10.5 million in seed funding… Read more »

robot typing
AI/Machine Learning

A VC analyst spoke to 50 AI startup founders to understand who to invest in – here’s what she found

- March 8, 2023 2 MIN READ

In my first few months working in deep-tech venture capital, I found and spoke to more than 50 founders building ‘AI’ companies. From climate to workflow to healthcare to transports and logistics to aged care, I canvassed the AI startup space in Australia, meeting incredible founders and gaining useful insight about the Australian AI ecosystem.… Read more »

money plant grow
Business strategy

5 reasons why every founder needs to make ESG part of their startup’s DNA

- February 9, 2023 2 MIN READ

ESG plans and action are increasingly expected from earlier-stage startups and are a non-negotiable requirement for later-stage companies gearing up to IPO. I’m a big believer that implementing ESG early can have a powerful positive effect on your company build.As an investor at Main Sequence, we have seen countless times companies who have a purposeful… Read more »


Bondi GP and angel investor Dr Amandeep Hansra joins Main Sequence as principal

- October 20, 2022 2 MIN READ

Sydney doctor, founder and angel investor Dr Amandeep Hansra has joined the CSIRO’s deep tech investment fund Main Sequence as a principal. Dr Hansra, a Bondi GP, has been in general practice for nearly two decades and co-founded the investment syndicate Australian Medical Angels, as well as founing Creative Careers in Medicine, which provides consulting services… Read more »

R&D, science

CSIRO’s VC fund Main Sequence is backing biotech startups in a new UNSW accelerator

- March 28, 2022 2 MIN READ

The University of NSW entrepreneurship program, UNSW Founders, will launch a new venture-backed accelerator for deep tech startups focused on synthetic biology and biotech with support from the CSIRO’s VC arm, Main Sequence. SynBio 10x will run in conjunction with the RNA Institute and UNSW School of Biotechnology & Biomolecular Sciences. Main Sequence will invest $120,000… Read more »

Quantum Brilliance co-founders
Other tech

A quantum startup using synthetic diamonds to accelerate computing has raised $13 million in seed funding

- August 26, 2021 2 MIN READ

Canberra-based computing science startup Quantum Brilliance has raised US$10 million (A$13m) in seed funding. The investment into the Australian-German full-stack quantum accelerator startup, which emerged from The ANU’s research group in diamond quantum science in 2019, was co-led by the QxBranch founders’ and the CSIRO’s VC fund, Main Sequence, with other backers including CP Ventures, Investible,… Read more »